Treatment for Diabetic Neuropathy Using Repetitive Transcranial Magnetic Stimulation
Key facts
- Who runs it
- McMaster University
- Where
- Canada1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 18 people enrolled
- Started
- 1 Jan 2025
- Ended
- 31 Dec 2025
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Sham Repetitive transcranial magnetic stimulation
- Repetitive transcranial magnetic stimulation
- Record updated
- 28 May 2026
Who can take part
- Age
- 20 years to 75 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- A diagnosis of diabetic neuropathy
Who cannot take part
- Contraindications to transcranial magnetic stimulation
- Known psychological diagnosis affecting comprehension
- Inability to participate in the study
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The aim of this study is to determine whether a 4-week treatment of repetitive transcranial magnetic stimulation (rTMS) can alleviate the symptoms of neuropathy in individuals with diabetic neuropathy. The study will involve using questionnaires, nerve assessments, sensory tests, blood flow measurements, and blood tests to monitor any changes in symptoms after the rTMS intervention.
The 2 groups in the trial
- Group A (Sham)Sham treatment, for comparison
Participants in group A will take part in 4 weeks of treatment with 5 sessions per week. Each session will involve sham repetitive transcranial magnetic stimulation (rTMS). Sham rTMS will be delivered at 10 Hz, 2004 pulses targeting the leg representation of the primary motor cortex. Participants will hear and experience the clicking but will not be provided with any stimulation. Sham rTMS will take approximately 11.5 minutes.
Treatment: Sham Repetitive transcranial magnetic stimulation
- Group B (Active)Existing treatment, for comparison
Participants in group B will take part in 4 weeks of treatment with 5 sessions per week. Each session will involve real repetitive transcranial magnetic stimulation (rTMS). rTMS will be delivered at 10 Hz, 2004 pulses targeting the leg representation of the primary motor cortex. rTMS will take approximately 11.5 minutes.
Treatment: Repetitive transcranial magnetic stimulation
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Effects of Repetitive Transcranial Magnetic Stimulation on Neuropathy in Diabetic Neuropathy: A Pilot Study
- Record updated
- 28 May 2026